Multilocus sequence type analysis reveals both clonality and recombination in populations of Candida glabrata bloodstream isolates from U.S. surveillance studies

Eukaryotic Cell

Volumn 9, Issue 4, 2010, Pages 619-625

  Lott, Timothy J ^a   Frade, João P ^a   Lockhart, Shawn R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM IDENTIFICATION; BLOOD; CANDIDA GLABRATA; CANDIDIASIS; CLASSIFICATION; CROSS INFECTION; DNA SEQUENCE; GENETIC RECOMBINATION; GENETICS; GENOTYPE; HEALTH SURVEY; HUMAN; METABOLISM; MICROBIOLOGY; PHYLOGENY; POPULATION GENETICS; UNITED STATES; GEORGIA;

BACTERIAL TYPING TECHNIQUES; BALTIMORE; CANDIDA GLABRATA; CANDIDIASIS; CROSS INFECTION; GENETICS, POPULATION; GENOTYPE; GEORGIA; HUMANS; PHYLOGENY; POPULATION SURVEILLANCE; RECOMBINATION, GENETIC; SAN FRANCISCO; SEQUENCE ANALYSIS, DNA;

CANDIDA GLABRATA;

EID: 77950531123     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00002-10     Document Type: Article

References (24)

1. Agapow, P.-M., and A. Burt. 2001. Indices of multilocus linkage disequilibrium. Mol. Ecol. Notes 1:101-102.
2. Ahlquist, A., M. M. Farley, L. H. Harrison, W. Baughman, B. Siegel, R. Hollick, S. R. Lockhart, S. S. Magill, and T. Chiller. 2009. Epidemiology of candidemia in metropolitan Atlanta and Baltimore City and County: preliminary results of population-based active, laboratory surveillance-2008-2010, abstr. M-1241. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother., San Francisco, CA.
3. Brisse, S., C. Pannier, A. Angoulvant, T. deMeeus, L. Diancourt, O. Faure, H. Muller, J. Peman, M. A. Viviani, R. Grillot, B. Dujon, C. Fairhead, and C. Hennequin. 2009. Uneven distribution of mating types among genotypes of Candida glabrata isolates from clinical samples. Eukaryot. Cell 8:287-295.
4. Dodgson, A. R., C. Pujol, D. W. Denning, D. R. Soll, and A. J. Fox. 2003. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J. Clin. Microbiol. 41:5709-5717.
5. Dodgson, A. R., C. Pujol, M. A. Pfaller, D. W. Denning, and D. R. Soll. 2005. Evidence for recombination in Candida glabrata. Fung. Genet. Biol. 42:233-243.
6. Felsenstein, J. 1973. Maximum likelihood and minimum-step methods for estimating evolutionary trees from data on discrete characters. Syst. Zool. 22:240-249.
7. Fidel, P. L., Jr., J. A. Vazquez, and J. D. Sobel. 1999. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 12:80-96.
8. Hajjeh, R. A., N. A. Sofair, L. H. Harrison, G. M. Lyon, B. A. Arthington-Skaggs, S. A. Mirza, M. Phelan, J. Morgan, W. Lee-Yang, M. A. Ciblak, L. E. Benjamin, L. T. Sanza, S. Huie, S. F. Yeo, M. E. Brandt, and D. W. Warnock. 2004. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a populationbased active surveillance program. J. Clin. Microbiol. 42:1519-1527.
9. Hartl, D. L., and A. G. Clark. 1997. Principles of population genetics, 3rd ed. Sinauer Associates, Inc., Sunderland, MA.
10. Kao, A. S., M. E. Brandt, W. R. Pruitt, L. A. Conn, B. A. Perkins, D. S. Stevens, W. S. Baughman, A. L. Reingold, G. A. Rothrock, M. A. Pfaller, R. W. Pinner, and R. A. Hajjeh. 1999. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin. Infect. Dis. 29:1164-1170.
11. Lin, C. Y., Y. C. Chen, H. J. Lo, K. W. Chen, and S. Y. Li. 2007. Assessment of Candida glabrata strain relatedness by pulsed-field gel electrophoresis and multilocus sequence typing. J. Clin. Microbiol. 45:2452-2459.
12. Odds, F. C., M. F. Hanson, A. D. Davidson, M. D. Jacobsen, P. Wright, J. A. Whyte, N. A. Gow, and B. L. Jones. 2007. One year prospective survey of Candida bloodstream infections in Scotland. J. Med. Microbiol. 56:1066-1075.
13. Odds, F. C., and M. D. Jacobsen. 2008. Multilocis sequence typing of pathogenic Candida species. Eukaryot. Cell 7:1075-1084.
14. Pfaller, M. A., and D. J. Diekema. 2007. The epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20:133-163.
15. Pfaller, M. A., D. J. Diekema, D. L. Gibbs, V. A. Newell, J. F. Meis, I. M. Gould, W. Fu, A. L. Colombo, E. Rodriguez-Noriega, and the Global Antifungal Surveillance Group. 2007. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J. Clin. Microbiol. 45:1735-1745.
16. Pond, S. L. S. D. Frost, and S. V. Muse. 2005. HyPhy: hypothesis testing using phylogenies. Bioinformatics 21:676-679.
17. Raymond, M., and F. Rousset. 1995. GENEPOP (version 1.3): population genetics software for exact tests and ecumenicism. J. Hered. 86:248-249.
18. Sherman, D. J., T. Martin, M. Nikolski, C. Cayla, J. L. Souciet, P. Durrens, and the Genolevures Consortium. 2009. Genolevures: protein families and synteny among complete hemiascomycetous yeast proteomes and genomes. Nucleic Acids Res. 37:D550-D554.
19. Soll, D. R. 2000. The ins and outs of DNA fingerprinting the infectious fungi. Clin. Microbiol. Rev. 13:332-370.
20. Tamura, K., J. Dudley, M. Nei, and S. Kumar. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599.
21. Trick, W. E., S. K. Fridkin, J. R. Edwards, R. A. Hajjeh, R. P. Gaynes, et al. 2002. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin. Infect. Dis. 35: 627-630.
22. Urwin, R., and C. J. Maiden. 2003. Multi-locus sequence typing: a tool for global epidemiology. Trends Microbiol. 11:479-487.
23. Weir, B. S. 1996. Genetic data analysis II. Sinauer, Sunderland, MA.
24. Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.